C3a‐ C3aR Signaling Modulates Neutrophil Extracellular Traps Formation and Contributes to Blood–Brain Barrier Injury After Stroke
CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)
DOI: 10.1002/cns.71239 ↗Abstract
ABSTRACT Background Stroke causes severe neurological damage, blood–brain barrier (BBB) dysfunction, complement activation, and neutrophil infiltration. How complement signaling interacts with infiltrating neutrophils in BBB dysfunction remains unclear. Purpose This study aims to elucidate how the C3a‐C3aR axis modulates neutrophil extracellular traps (NETs) formation and thereby contributes to BBB disruption following stroke. Methods A transient middle cerebral artery occlusion (tMCAO) rat model was used to induce ischemic stroke. Neurological function, infarct volume, and BBB integrity were assessed using behavioral tests, TTC staining, electron microscopy, and BBB permeability assays. Molecular and histological analyses, including RNA sequencing, immunostaining, HE staining, Nissl staining, ELISA, RT‐qPCR, Co‐IP, and western blotting, were performed to evaluate complement activation, NETs, and inflammatory responses. The C3a‐C3aR axis and NETs formation were pharmacologically modulated to determine their roles in post‐stroke BBB damage. Results BBB damage, neutrophil infiltration, and neurobehavioral deficits are prominent after stroke. On the third day after the stroke, BBB damage is most pronounced. RNA sequencing revealed that inflammatory responses, complement activation, and NETs formation were identified as central mechanisms. Key driver analysis confirmed that C3a‐C3aR signaling was associated with neutrophil responses and NETs formation. Increased numbers of neutrophils infiltrated the brain parenchyma and formed NETs after stroke, in association with BBB damage and neurological injury. C3aR was expressed in neutrophils, consistent with a potential role of C3a‐C3aR signaling in neutrophil responses. Inhibiting NETs formation mitigated these poor functional outcomes, ameliorating BBB dysfunction. C3a‐C3aR signaling was associated with NETs formation and BBB disruption and neurological injury. Suppression of C3a‐C3aR signaling reduced NETs formation and was associated with attenuated BBB disruption and neurological impairment. Conversely, activation of C3a‐C3aR signaling was associated with increased NETs formation, BBB disruption, and neurological damage. Conclusion Thus, our results indicate that C3a‐C3aR signaling is associated with NETs formation, BBB damage, and neurological impairment after stroke and may represent a potential target for further investigation.
EUVIMED